EyePoint grants inducement awards under Nasdaq Rule 5635(c)(4)
EyePoint Pharmaceuticals reports inducement grants under Nasdaq Listing Rule 5635(c)(4) for EYPT.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.